Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,959 | -9,207 | -13,183 | -33,277 | -25,175 |
| Depreciation Amortization | 2,102 | 1,363 | 605 | 2,770 | 2,195 |
| Accounts receivable | N/A | N/A | N/A | -2,624 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -4,208 | N/A |
| Other Working Capital | -33,933 | -18,285 | 607 | -33,370 | -27,389 |
| Other Operating Activity | 17,640 | 1,702 | 975 | 10,777 | 3,370 |
| Operating Cash Flow | $-34,150 | $-24,427 | $-10,996 | $-59,932 | $-46,999 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -184 | -115 | -48 | -1,041 | -1,052 |
| Purchase Of Investment | -15,270 | -8,243 | -1,544 | -48,395 | -43,191 |
| Sale Of Investment | 24,007 | 18,895 | 13,495 | 28,200 | 21,900 |
| Investing Cash Flow | $8,553 | $10,537 | $11,903 | $-21,236 | $-22,343 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 19,781 | 19,781 | N/A | 7,214 | 7,121 |
| Financing Cash Flow | $19,781 | $19,781 | $N/A | $7,214 | $7,121 |
| Exchange Rate Effect | 75 | 412 | 200 | -5,175 | -7,120 |
| Beginning Cash Position | 38,635 | 38,635 | 38,635 | 117,764 | 117,764 |
| End Cash Position | 32,894 | 44,938 | 39,742 | 38,635 | 48,423 |
| Net Cash Flow | $-5,741 | $6,303 | $1,107 | $-79,129 | $-69,341 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,150 | -24,427 | -10,996 | -59,932 | -46,999 |
| Capital Expenditure | -184 | -115 | -48 | -1,041 | -1,052 |
| Free Cash Flow | -34,334 | -24,542 | -11,044 | -60,973 | -48,051 |